Patent ID: 11911396
Assignee: GUANGZHOU CELLPROTEK PHARMACEUTICAL CO., LTD
Field: Pharmaceuticals (Chemistry)
Classification: CPC A | IPC A

Claim 0:
1. A method for treating a cerebral microbleed in a patient suffering from a cerebral microbleed, the method comprising administering to the patient an effective amount of a compound of formula I:, or a deuterated compound or a pharmaceutically acceptable salt thereof,
wherein R1 is H, an alkyl having 1 to 5 carbon atoms, or —CH(CH3)(CH2)3CH(CH3)2,
wherein the cerebral microbleed manifests as an increased distribution of free hemoglobin outside cerebral vessels; and
wherein the cerebral microbleed is treated by clearing free hemoglobin outside the cerebral vessels in the patient.